The plasma levels of ADAM9 mRNA were tested in the five newly diagnosed and treatment-naïve HCC patients (Table 1, Subject #1 to #5) and expressed as fold changes compared to the healthy control group (n = 5, 100% female, mean age 34.2 years). This evidence concerns the gene ADAM9 and hepatocellular carcinoma.